Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.
Saved in:
| Title: | Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. |
|---|---|
| Authors: | Eastell R; Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK. r.eastell@sheffield.ac.uk., Mitlak BH; Radius Health, Inc., Waltham, MA, USA., Wang Y; Radius Health, Inc., Waltham, MA, USA., Hu M; Radius Health, Inc., Waltham, MA, USA., Fitzpatrick LA; Radius Health, Inc., Waltham, MA, USA., Black DM; University of California, San Francisco, CA, USA. |
| Source: | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2019 Mar; Vol. 30 (3), pp. 667-673. Date of Electronic Publication: 2019 Jan 11. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1433-2965 |
|---|---|
| DOI: | 10.1007/s00198-018-04819-1 |
